Evidence map›Paper›PMID 31933626›Full record

ArticleNeural plasticity2019

Changes in the Fluorescence Tracking of NaV1.6 Protein Expression in a BTBR T+Itpr3tf/J Autistic Mouse Model.

Musaad A Alshammari, Mohammad R Khan, Fawaz Alasmari, Abdulaziz O Alshehri, Rizwan Ali, Mohamed Boudjelal, Khalid A Alhosaini, Abdurahman A Niazy, Tahani K Alshammari

Open access · goldAbstract read
In one paragraph

Article in Neural plasticity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Melatonin AttenuatesInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Cathepsin-B inhibitor CA-074 attenuates retinopathy and optic neuritis in experimental autoimmune encephalomyelitis induced in SJL/J mice.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Musaad A AlshammariDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Saudi Arabia.
Mohammad R KhanDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Saudi Arabia.
Fawaz AlasmariDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Saudi Arabia.ORCID 0000-0003-2382-5892
Abdulaziz O AlshehriDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Saudi Arabia.
Rizwan AliMedical Research Core Facilities & Platforms, King Abdullah International Medical Research Center, Saudi Arabia.
Mohamed BoudjelalMedical Research Core Facilities & Platforms, King Abdullah International Medical Research Center, Saudi Arabia.
Khalid A AlhosainiDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Saudi Arabia.
Abdurahman A NiazyPrince Naif Bin Abdulaziz Health Research Center (PNHRC), King Saud University, Saudi Arabia.
Tahani K AlshammariDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Saudi Arabia.ORCID 0000-0002-2211-1014
King Saud bin Abdulaziz University for Health Sciences · SAKing Saud University · SAKing Abdullah International Medical Research Center · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The axon initial segment (AIS), the site of action potential initiation in neurons, is a critical determinant of neuronal excitability. Growing evidence indicates that appropriate recruitment of the AIS macrocomplex is essential for synchronized firing. However, disruption of the AIS structure is linked to the etiology of multiple disorders, including autism spectrum disorder (ASD), a condition characterized by deficits in social communication, stereotyped behaviors, and very limited interests. To date, a complete understanding of the molecular components that underlie the AIS in ASD has remained elusive. In this research, we examined the AIS structure in a BTBR T+Itpr3tf/J mouse model (BTBR), a valid model that exhibits behavioral, electrical, and molecular features of autism, and compared this to the C57BL/6J wild-type control mouse. Using Western blot studies and high-resolution confocal microscopy in the prefrontal frontal cortex (PFC), our data indicate disrupted expression of different isoforms of the voltage-gated sodium channels (NaV) at the AIS, whereas other components of AIS such as ankyrin-G and fibroblast growth factor 14 (FGF14) and contactin-associated protein 1 (Caspr) in BTBR were comparable to those in wild-type control mice. A Western blot assay showed that BTBR mice exhibited a marked increase in different sodium channel isoforms in the PFC compared to wild-type mice. Our results provide potential evidence for previously undescribed mechanisms that may play a role in the pathogenesis of autistic-like phenotypes in BTBR mice.

Indexed as

Disease Models, AnimalAnimalsAutistic DisorderGene ExpressionMaleMiceMice, Inbred C57BLMice, TransgenicNAV1.6 Voltage-Gated Sodium ChannelOptical ImagingNAV1.6 Voltage-Gated Sodium ChannelScn8a protein, mouse

Identifiers

PMID31933626
PMCPMC6942885
OpenAlexW2995039877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.